nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—Cholesterol biosynthesis—DHCR24—Alzheimer's disease	0.037	0.364	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—AMFR—Alzheimer's disease	0.0196	0.192	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—GSK3A—Alzheimer's disease	0.00423	0.0416	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPL—Alzheimer's disease	0.00299	0.0293	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00274	0.0269	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PPARG—Alzheimer's disease	0.00218	0.0214	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—CREB1—Alzheimer's disease	0.00215	0.0211	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—INS—Alzheimer's disease	0.00214	0.021	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.00198	0.0195	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00183	0.018	CbGpPWpGaD
Ibandronate—Malnutrition—Galantamine—Alzheimer's disease	0.00181	0.00202	CcSEcCtD
Ibandronate—Pneumonia—Donepezil—Alzheimer's disease	0.00181	0.00201	CcSEcCtD
Ibandronate—Bronchospasm—Memantine—Alzheimer's disease	0.0018	0.002	CcSEcCtD
Ibandronate—Infestation—Donepezil—Alzheimer's disease	0.00179	0.002	CcSEcCtD
Ibandronate—Infestation NOS—Donepezil—Alzheimer's disease	0.00179	0.002	CcSEcCtD
Ibandronate—Depression—Donepezil—Alzheimer's disease	0.00179	0.002	CcSEcCtD
Ibandronate—Dysphagia—Rivastigmine—Alzheimer's disease	0.00179	0.00199	CcSEcCtD
Ibandronate—Flatulence—Galantamine—Alzheimer's disease	0.00178	0.00199	CcSEcCtD
Ibandronate—Dysgeusia—Galantamine—Alzheimer's disease	0.00177	0.00198	CcSEcCtD
Ibandronate—Renal failure—Donepezil—Alzheimer's disease	0.00176	0.00197	CcSEcCtD
Ibandronate—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00176	0.00196	CcSEcCtD
Ibandronate—Bronchitis—Memantine—Alzheimer's disease	0.00176	0.00196	CcSEcCtD
Ibandronate—Back pain—Galantamine—Alzheimer's disease	0.00175	0.00195	CcSEcCtD
Ibandronate—Urinary tract infection—Donepezil—Alzheimer's disease	0.00174	0.00194	CcSEcCtD
Ibandronate—Muscle spasms—Galantamine—Alzheimer's disease	0.00174	0.00194	CcSEcCtD
Ibandronate—Sweating—Donepezil—Alzheimer's disease	0.00172	0.00192	CcSEcCtD
Ibandronate—Bronchitis—Rivastigmine—Alzheimer's disease	0.00172	0.00192	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.0017	0.00189	CcSEcCtD
Ibandronate—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00168	0.00187	CcSEcCtD
Ibandronate—Anaemia—Galantamine—Alzheimer's disease	0.00167	0.00186	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00166	0.00185	CcSEcCtD
Ibandronate—Weight decreased—Memantine—Alzheimer's disease	0.00165	0.00184	CcSEcCtD
Ibandronate—Pneumonia—Memantine—Alzheimer's disease	0.00164	0.00183	CcSEcCtD
Ibandronate—Malaise—Galantamine—Alzheimer's disease	0.00163	0.00182	CcSEcCtD
Ibandronate—Infestation—Memantine—Alzheimer's disease	0.00163	0.00182	CcSEcCtD
Ibandronate—Infestation NOS—Memantine—Alzheimer's disease	0.00163	0.00182	CcSEcCtD
Ibandronate—Vertigo—Galantamine—Alzheimer's disease	0.00163	0.00181	CcSEcCtD
Ibandronate—Depression—Memantine—Alzheimer's disease	0.00162	0.00181	CcSEcCtD
Ibandronate—Haemoglobin—Donepezil—Alzheimer's disease	0.00162	0.00181	CcSEcCtD
Ibandronate—Weight decreased—Rivastigmine—Alzheimer's disease	0.00162	0.0018	CcSEcCtD
Ibandronate—Haemorrhage—Donepezil—Alzheimer's disease	0.00161	0.0018	CcSEcCtD
Ibandronate—Pneumonia—Rivastigmine—Alzheimer's disease	0.0016	0.00179	CcSEcCtD
Ibandronate—Renal failure—Memantine—Alzheimer's disease	0.0016	0.00179	CcSEcCtD
Ibandronate—Palpitations—Galantamine—Alzheimer's disease	0.0016	0.00178	CcSEcCtD
Ibandronate—Pharyngitis—Donepezil—Alzheimer's disease	0.0016	0.00178	CcSEcCtD
Ibandronate—Infestation—Rivastigmine—Alzheimer's disease	0.00159	0.00178	CcSEcCtD
Ibandronate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00159	0.00178	CcSEcCtD
Ibandronate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00159	0.00177	CcSEcCtD
Ibandronate—Depression—Rivastigmine—Alzheimer's disease	0.00159	0.00177	CcSEcCtD
Ibandronate—Oedema peripheral—Donepezil—Alzheimer's disease	0.00159	0.00177	CcSEcCtD
Ibandronate—Urinary tract infection—Memantine—Alzheimer's disease	0.00158	0.00177	CcSEcCtD
Ibandronate—Urethral disorder—Donepezil—Alzheimer's disease	0.00158	0.00176	CcSEcCtD
Ibandronate—Renal failure—Rivastigmine—Alzheimer's disease	0.00157	0.00175	CcSEcCtD
Ibandronate—Hypertension—Galantamine—Alzheimer's disease	0.00156	0.00174	CcSEcCtD
Ibandronate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00155	0.00173	CcSEcCtD
Ibandronate—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Ibandronate—Arthralgia—Galantamine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Ibandronate—Myalgia—Galantamine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Ibandronate—Chest pain—Galantamine—Alzheimer's disease	0.00154	0.00172	CcSEcCtD
Ibandronate—Anxiety—Galantamine—Alzheimer's disease	0.00154	0.00171	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00153	0.00171	CcSEcCtD
Ibandronate—Sweating—Rivastigmine—Alzheimer's disease	0.00153	0.0017	CcSEcCtD
Ibandronate—Discomfort—Galantamine—Alzheimer's disease	0.00152	0.0017	CcSEcCtD
Ibandronate—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00151	0.00168	CcSEcCtD
Ibandronate—Dry mouth—Galantamine—Alzheimer's disease	0.00151	0.00168	CcSEcCtD
Ibandronate—Haemoglobin—Memantine—Alzheimer's disease	0.00147	0.00164	CcSEcCtD
Ibandronate—Haemorrhage—Memantine—Alzheimer's disease	0.00146	0.00163	CcSEcCtD
Ibandronate—Shock—Galantamine—Alzheimer's disease	0.00145	0.00162	CcSEcCtD
Ibandronate—Pharyngitis—Memantine—Alzheimer's disease	0.00145	0.00162	CcSEcCtD
Ibandronate—Nervous system disorder—Galantamine—Alzheimer's disease	0.00145	0.00161	CcSEcCtD
Ibandronate—Chills—Donepezil—Alzheimer's disease	0.00145	0.00161	CcSEcCtD
Ibandronate—Urinary tract disorder—Memantine—Alzheimer's disease	0.00144	0.00161	CcSEcCtD
Ibandronate—Oedema peripheral—Memantine—Alzheimer's disease	0.00144	0.00161	CcSEcCtD
Ibandronate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00144	0.0016	CcSEcCtD
Ibandronate—Connective tissue disorder—Memantine—Alzheimer's disease	0.00144	0.0016	CcSEcCtD
Ibandronate—Skin disorder—Galantamine—Alzheimer's disease	0.00143	0.0016	CcSEcCtD
Ibandronate—Urethral disorder—Memantine—Alzheimer's disease	0.00143	0.0016	CcSEcCtD
Ibandronate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00143	0.0016	CcSEcCtD
Ibandronate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00143	0.00159	CcSEcCtD
Ibandronate—Alopecia—Donepezil—Alzheimer's disease	0.00142	0.00159	CcSEcCtD
Ibandronate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00142	0.00158	CcSEcCtD
Ibandronate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00141	0.00158	CcSEcCtD
Ibandronate—Mental disorder—Donepezil—Alzheimer's disease	0.00141	0.00157	CcSEcCtD
Ibandronate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00141	0.00157	CcSEcCtD
Ibandronate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00141	0.00157	CcSEcCtD
Ibandronate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Ibandronate—Erythema—Donepezil—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Ibandronate—Malnutrition—Donepezil—Alzheimer's disease	0.0014	0.00156	CcSEcCtD
Ibandronate—Flatulence—Donepezil—Alzheimer's disease	0.00138	0.00154	CcSEcCtD
Ibandronate—Dysgeusia—Donepezil—Alzheimer's disease	0.00137	0.00153	CcSEcCtD
Ibandronate—Eye disorder—Memantine—Alzheimer's disease	0.00137	0.00152	CcSEcCtD
Ibandronate—Cardiac disorder—Memantine—Alzheimer's disease	0.00136	0.00151	CcSEcCtD
Ibandronate—Back pain—Donepezil—Alzheimer's disease	0.00136	0.00151	CcSEcCtD
Ibandronate—Muscle spasms—Donepezil—Alzheimer's disease	0.00135	0.0015	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00135	0.0015	CcSEcCtD
Ibandronate—Eye disorder—Rivastigmine—Alzheimer's disease	0.00134	0.00149	CcSEcCtD
Ibandronate—Insomnia—Galantamine—Alzheimer's disease	0.00134	0.00149	CcSEcCtD
Ibandronate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00133	0.00148	CcSEcCtD
Ibandronate—Angiopathy—Memantine—Alzheimer's disease	0.00133	0.00148	CcSEcCtD
Ibandronate—Paraesthesia—Galantamine—Alzheimer's disease	0.00133	0.00148	CcSEcCtD
Ibandronate—Immune system disorder—Memantine—Alzheimer's disease	0.00132	0.00147	CcSEcCtD
Ibandronate—Mediastinal disorder—Memantine—Alzheimer's disease	0.00132	0.00147	CcSEcCtD
Ibandronate—Chills—Memantine—Alzheimer's disease	0.00131	0.00146	CcSEcCtD
Ibandronate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.0013	0.00145	CcSEcCtD
Ibandronate—Dyspepsia—Galantamine—Alzheimer's disease	0.0013	0.00145	CcSEcCtD
Ibandronate—Angiopathy—Rivastigmine—Alzheimer's disease	0.0013	0.00145	CcSEcCtD
Ibandronate—Anaemia—Donepezil—Alzheimer's disease	0.0013	0.00145	CcSEcCtD
Ibandronate—Alopecia—Memantine—Alzheimer's disease	0.00129	0.00144	CcSEcCtD
Ibandronate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00129	0.00144	CcSEcCtD
Ibandronate—Chills—Rivastigmine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Ibandronate—Decreased appetite—Galantamine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Ibandronate—Mental disorder—Memantine—Alzheimer's disease	0.00128	0.00143	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00128	0.00142	CcSEcCtD
Ibandronate—Malnutrition—Memantine—Alzheimer's disease	0.00127	0.00142	CcSEcCtD
Ibandronate—Fatigue—Galantamine—Alzheimer's disease	0.00127	0.00142	CcSEcCtD
Ibandronate—Malaise—Donepezil—Alzheimer's disease	0.00126	0.00141	CcSEcCtD
Ibandronate—Alopecia—Rivastigmine—Alzheimer's disease	0.00126	0.00141	CcSEcCtD
Ibandronate—Constipation—Galantamine—Alzheimer's disease	0.00126	0.00141	CcSEcCtD
Ibandronate—Vertigo—Donepezil—Alzheimer's disease	0.00126	0.0014	CcSEcCtD
Ibandronate—Flatulence—Memantine—Alzheimer's disease	0.00125	0.0014	CcSEcCtD
Ibandronate—Mental disorder—Rivastigmine—Alzheimer's disease	0.00125	0.0014	CcSEcCtD
Ibandronate—Dysgeusia—Memantine—Alzheimer's disease	0.00125	0.00139	CcSEcCtD
Ibandronate—Erythema—Rivastigmine—Alzheimer's disease	0.00125	0.00139	CcSEcCtD
Ibandronate—Malnutrition—Rivastigmine—Alzheimer's disease	0.00125	0.00139	CcSEcCtD
Ibandronate—Back pain—Memantine—Alzheimer's disease	0.00123	0.00137	CcSEcCtD
Ibandronate—Flatulence—Rivastigmine—Alzheimer's disease	0.00123	0.00137	CcSEcCtD
Ibandronate—FDPS—Metabolism—DHCR24—Alzheimer's disease	0.00122	0.012	CbGpPWpGaD
Ibandronate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00122	0.00136	CcSEcCtD
Ibandronate—Feeling abnormal—Galantamine—Alzheimer's disease	0.00122	0.00136	CcSEcCtD
Ibandronate—Risedronate—PTGS2—Alzheimer's disease	0.00122	1	CrCbGaD
Ibandronate—Hypertension—Donepezil—Alzheimer's disease	0.00121	0.00135	CcSEcCtD
Ibandronate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00121	0.00135	CcSEcCtD
Ibandronate—Back pain—Rivastigmine—Alzheimer's disease	0.0012	0.00134	CcSEcCtD
Ibandronate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0012	0.00134	CcSEcCtD
Ibandronate—Myalgia—Donepezil—Alzheimer's disease	0.00119	0.00133	CcSEcCtD
Ibandronate—Chest pain—Donepezil—Alzheimer's disease	0.00119	0.00133	CcSEcCtD
Ibandronate—Arthralgia—Donepezil—Alzheimer's disease	0.00119	0.00133	CcSEcCtD
Ibandronate—Anxiety—Donepezil—Alzheimer's disease	0.00119	0.00133	CcSEcCtD
Ibandronate—Ill-defined disorder—Memantine—Alzheimer's disease	0.00118	0.00132	CcSEcCtD
Ibandronate—Discomfort—Donepezil—Alzheimer's disease	0.00118	0.00132	CcSEcCtD
Ibandronate—Anaemia—Memantine—Alzheimer's disease	0.00118	0.00131	CcSEcCtD
Ibandronate—Dry mouth—Donepezil—Alzheimer's disease	0.00117	0.0013	CcSEcCtD
Ibandronate—Abdominal pain—Galantamine—Alzheimer's disease	0.00117	0.0013	CcSEcCtD
Ibandronate—Body temperature increased—Galantamine—Alzheimer's disease	0.00117	0.0013	CcSEcCtD
Ibandronate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00129	CcSEcCtD
Ibandronate—Anaemia—Rivastigmine—Alzheimer's disease	0.00115	0.00128	CcSEcCtD
Ibandronate—Malaise—Memantine—Alzheimer's disease	0.00115	0.00128	CcSEcCtD
Ibandronate—Vertigo—Memantine—Alzheimer's disease	0.00114	0.00128	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.00114	0.0112	CbGpPWpGaD
Ibandronate—Infection—Donepezil—Alzheimer's disease	0.00114	0.00127	CcSEcCtD
Ibandronate—Shock—Donepezil—Alzheimer's disease	0.00113	0.00126	CcSEcCtD
Ibandronate—Palpitations—Memantine—Alzheimer's disease	0.00113	0.00125	CcSEcCtD
Ibandronate—Malaise—Rivastigmine—Alzheimer's disease	0.00112	0.00125	CcSEcCtD
Ibandronate—Nervous system disorder—Donepezil—Alzheimer's disease	0.00112	0.00125	CcSEcCtD
Ibandronate—Vertigo—Rivastigmine—Alzheimer's disease	0.00112	0.00125	CcSEcCtD
Ibandronate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00111	0.00123	CcSEcCtD
Ibandronate—Palpitations—Rivastigmine—Alzheimer's disease	0.0011	0.00123	CcSEcCtD
Ibandronate—Hypertension—Memantine—Alzheimer's disease	0.0011	0.00123	CcSEcCtD
Ibandronate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00109	0.00121	CcSEcCtD
Ibandronate—Chest pain—Memantine—Alzheimer's disease	0.00108	0.00121	CcSEcCtD
Ibandronate—Arthralgia—Memantine—Alzheimer's disease	0.00108	0.00121	CcSEcCtD
Ibandronate—Myalgia—Memantine—Alzheimer's disease	0.00108	0.00121	CcSEcCtD
Ibandronate—Anxiety—Memantine—Alzheimer's disease	0.00108	0.0012	CcSEcCtD
Ibandronate—Hypertension—Rivastigmine—Alzheimer's disease	0.00108	0.0012	CcSEcCtD
Ibandronate—Discomfort—Memantine—Alzheimer's disease	0.00107	0.00119	CcSEcCtD
Ibandronate—Arthralgia—Rivastigmine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Chest pain—Rivastigmine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Myalgia—Rivastigmine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Dry mouth—Memantine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Asthenia—Galantamine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Anxiety—Rivastigmine—Alzheimer's disease	0.00106	0.00118	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00105	0.00117	CcSEcCtD
Ibandronate—Discomfort—Rivastigmine—Alzheimer's disease	0.00105	0.00117	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00104	0.00116	CcSEcCtD
Ibandronate—FDPS—Metabolism—CA4—Alzheimer's disease	0.00104	0.0102	CbGpPWpGaD
Ibandronate—Dry mouth—Rivastigmine—Alzheimer's disease	0.00104	0.00116	CcSEcCtD
Ibandronate—Insomnia—Donepezil—Alzheimer's disease	0.00104	0.00115	CcSEcCtD
Ibandronate—Infection—Memantine—Alzheimer's disease	0.00103	0.00115	CcSEcCtD
Ibandronate—Paraesthesia—Donepezil—Alzheimer's disease	0.00103	0.00115	CcSEcCtD
Ibandronate—Shock—Memantine—Alzheimer's disease	0.00102	0.00114	CcSEcCtD
Ibandronate—Nervous system disorder—Memantine—Alzheimer's disease	0.00102	0.00114	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00102	0.00997	CbGpPWpGaD
Ibandronate—Diarrhoea—Galantamine—Alzheimer's disease	0.00101	0.00113	CcSEcCtD
Ibandronate—Infection—Rivastigmine—Alzheimer's disease	0.00101	0.00113	CcSEcCtD
Ibandronate—Skin disorder—Memantine—Alzheimer's disease	0.00101	0.00113	CcSEcCtD
Ibandronate—Dyspepsia—Donepezil—Alzheimer's disease	0.00101	0.00112	CcSEcCtD
Ibandronate—Hyperhidrosis—Memantine—Alzheimer's disease	0.001	0.00112	CcSEcCtD
Ibandronate—Shock—Rivastigmine—Alzheimer's disease	0.001	0.00112	CcSEcCtD
Ibandronate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000997	0.00111	CcSEcCtD
Ibandronate—Decreased appetite—Donepezil—Alzheimer's disease	0.000995	0.00111	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000988	0.0011	CcSEcCtD
Ibandronate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000987	0.0011	CcSEcCtD
Ibandronate—Fatigue—Donepezil—Alzheimer's disease	0.000987	0.0011	CcSEcCtD
Ibandronate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000983	0.0011	CcSEcCtD
Ibandronate—Pain—Donepezil—Alzheimer's disease	0.000979	0.00109	CcSEcCtD
Ibandronate—Constipation—Donepezil—Alzheimer's disease	0.000979	0.00109	CcSEcCtD
Ibandronate—FDPS—Metabolism—GAPDHS—Alzheimer's disease	0.000977	0.00959	CbGpPWpGaD
Ibandronate—Dizziness—Galantamine—Alzheimer's disease	0.000977	0.00109	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000947	0.00106	CcSEcCtD
Ibandronate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000943	0.00105	CcSEcCtD
Ibandronate—Insomnia—Memantine—Alzheimer's disease	0.00094	0.00105	CcSEcCtD
Ibandronate—Vomiting—Galantamine—Alzheimer's disease	0.000939	0.00105	CcSEcCtD
Ibandronate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000936	0.00104	CcSEcCtD
Ibandronate—Paraesthesia—Memantine—Alzheimer's disease	0.000933	0.00104	CcSEcCtD
Ibandronate—Rash—Galantamine—Alzheimer's disease	0.000931	0.00104	CcSEcCtD
Ibandronate—Dermatitis—Galantamine—Alzheimer's disease	0.00093	0.00104	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000926	0.00103	CcSEcCtD
Ibandronate—FDPS—Metabolism—ATP5A1—Alzheimer's disease	0.000926	0.00909	CbGpPWpGaD
Ibandronate—Headache—Galantamine—Alzheimer's disease	0.000925	0.00103	CcSEcCtD
Ibandronate—Insomnia—Rivastigmine—Alzheimer's disease	0.00092	0.00103	CcSEcCtD
Ibandronate—Dyspepsia—Memantine—Alzheimer's disease	0.000915	0.00102	CcSEcCtD
Ibandronate—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000913	0.00102	CcSEcCtD
Ibandronate—Urticaria—Donepezil—Alzheimer's disease	0.000909	0.00101	CcSEcCtD
Ibandronate—Body temperature increased—Donepezil—Alzheimer's disease	0.000905	0.00101	CcSEcCtD
Ibandronate—Abdominal pain—Donepezil—Alzheimer's disease	0.000905	0.00101	CcSEcCtD
Ibandronate—Decreased appetite—Memantine—Alzheimer's disease	0.000903	0.00101	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000897	0.001	CcSEcCtD
Ibandronate—Fatigue—Memantine—Alzheimer's disease	0.000896	0.000999	CcSEcCtD
Ibandronate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000895	0.000998	CcSEcCtD
Ibandronate—Pain—Memantine—Alzheimer's disease	0.000889	0.000991	CcSEcCtD
Ibandronate—Constipation—Memantine—Alzheimer's disease	0.000889	0.000991	CcSEcCtD
Ibandronate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000884	0.000985	CcSEcCtD
Ibandronate—FDPS—Metabolism—PLD3—Alzheimer's disease	0.000883	0.00867	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000883	0.00867	CbGpPWpGaD
Ibandronate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000878	0.000979	CcSEcCtD
Ibandronate—Nausea—Galantamine—Alzheimer's disease	0.000877	0.000978	CcSEcCtD
Ibandronate—Fatigue—Rivastigmine—Alzheimer's disease	0.000877	0.000977	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000873	0.00857	CbGpPWpGaD
Ibandronate—Pain—Rivastigmine—Alzheimer's disease	0.000869	0.000969	CcSEcCtD
Ibandronate—Constipation—Rivastigmine—Alzheimer's disease	0.000869	0.000969	CcSEcCtD
Ibandronate—FDPS—SREBP signalling—AKT1—Alzheimer's disease	0.000862	0.00847	CbGpPWpGaD
Ibandronate—Feeling abnormal—Memantine—Alzheimer's disease	0.000856	0.000955	CcSEcCtD
Ibandronate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00085	0.000947	CcSEcCtD
Ibandronate—FDPS—Metabolism—HSD17B10—Alzheimer's disease	0.000847	0.00832	CbGpPWpGaD
Ibandronate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000843	0.00094	CcSEcCtD
Ibandronate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000838	0.000934	CcSEcCtD
Ibandronate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000831	0.000927	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000828	0.00813	CbGpPWpGaD
Ibandronate—Urticaria—Memantine—Alzheimer's disease	0.000826	0.00092	CcSEcCtD
Ibandronate—Abdominal pain—Memantine—Alzheimer's disease	0.000822	0.000916	CcSEcCtD
Ibandronate—Body temperature increased—Memantine—Alzheimer's disease	0.000822	0.000916	CcSEcCtD
Ibandronate—Asthenia—Donepezil—Alzheimer's disease	0.000821	0.000916	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP46A1—Alzheimer's disease	0.000815	0.00801	CbGpPWpGaD
Ibandronate—Pruritus—Donepezil—Alzheimer's disease	0.00081	0.000903	CcSEcCtD
Ibandronate—Urticaria—Rivastigmine—Alzheimer's disease	0.000808	0.0009	CcSEcCtD
Ibandronate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000804	0.000896	CcSEcCtD
Ibandronate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000804	0.000896	CcSEcCtD
Ibandronate—FDPS—Metabolism—ND1—Alzheimer's disease	0.000787	0.00773	CbGpPWpGaD
Ibandronate—Diarrhoea—Donepezil—Alzheimer's disease	0.000783	0.000873	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00077	0.00756	CbGpPWpGaD
Ibandronate—Hypersensitivity—Memantine—Alzheimer's disease	0.000766	0.000854	CcSEcCtD
Ibandronate—Dizziness—Donepezil—Alzheimer's disease	0.000757	0.000844	CcSEcCtD
Ibandronate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000749	0.000835	CcSEcCtD
Ibandronate—Asthenia—Memantine—Alzheimer's disease	0.000746	0.000831	CcSEcCtD
Ibandronate—Pruritus—Memantine—Alzheimer's disease	0.000735	0.00082	CcSEcCtD
Ibandronate—Asthenia—Rivastigmine—Alzheimer's disease	0.000729	0.000813	CcSEcCtD
Ibandronate—Vomiting—Donepezil—Alzheimer's disease	0.000728	0.000811	CcSEcCtD
Ibandronate—Rash—Donepezil—Alzheimer's disease	0.000722	0.000805	CcSEcCtD
Ibandronate—Dermatitis—Donepezil—Alzheimer's disease	0.000721	0.000804	CcSEcCtD
Ibandronate—Pruritus—Rivastigmine—Alzheimer's disease	0.000719	0.000802	CcSEcCtD
Ibandronate—Headache—Donepezil—Alzheimer's disease	0.000717	0.000799	CcSEcCtD
Ibandronate—Diarrhoea—Memantine—Alzheimer's disease	0.000711	0.000793	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000704	0.00691	CbGpPWpGaD
Ibandronate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000696	0.000776	CcSEcCtD
Ibandronate—Dizziness—Memantine—Alzheimer's disease	0.000687	0.000766	CcSEcCtD
Ibandronate—Nausea—Donepezil—Alzheimer's disease	0.00068	0.000758	CcSEcCtD
Ibandronate—Dizziness—Rivastigmine—Alzheimer's disease	0.000672	0.00075	CcSEcCtD
Ibandronate—Vomiting—Memantine—Alzheimer's disease	0.000661	0.000737	CcSEcCtD
Ibandronate—Rash—Memantine—Alzheimer's disease	0.000655	0.000731	CcSEcCtD
Ibandronate—Dermatitis—Memantine—Alzheimer's disease	0.000655	0.00073	CcSEcCtD
Ibandronate—Headache—Memantine—Alzheimer's disease	0.000651	0.000726	CcSEcCtD
Ibandronate—Vomiting—Rivastigmine—Alzheimer's disease	0.000646	0.000721	CcSEcCtD
Ibandronate—Rash—Rivastigmine—Alzheimer's disease	0.000641	0.000715	CcSEcCtD
Ibandronate—Dermatitis—Rivastigmine—Alzheimer's disease	0.00064	0.000714	CcSEcCtD
Ibandronate—Headache—Rivastigmine—Alzheimer's disease	0.000637	0.00071	CcSEcCtD
Ibandronate—Nausea—Memantine—Alzheimer's disease	0.000617	0.000688	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000607	0.00596	CbGpPWpGaD
Ibandronate—Nausea—Rivastigmine—Alzheimer's disease	0.000604	0.000673	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000552	0.00542	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CHAT—Alzheimer's disease	0.000507	0.00498	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—TPI1—Alzheimer's disease	0.000507	0.00498	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MAOB—Alzheimer's disease	0.000486	0.00478	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GAPDH—Alzheimer's disease	0.000468	0.0046	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000463	0.00455	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000459	0.0045	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—A2M—Alzheimer's disease	0.000452	0.00444	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000403	0.00396	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACHE—Alzheimer's disease	0.000393	0.00386	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INPP5D—Alzheimer's disease	0.000389	0.00382	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS1—Alzheimer's disease	0.000369	0.00362	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ENO1—Alzheimer's disease	0.000369	0.00362	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2D6—Alzheimer's disease	0.000362	0.00355	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—BCHE—Alzheimer's disease	0.000343	0.00337	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PLCB1—Alzheimer's disease	0.000323	0.00318	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000317	0.00311	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ABCA1—Alzheimer's disease	0.000313	0.00308	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARGC1A—Alzheimer's disease	0.00027	0.00265	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HMOX1—Alzheimer's disease	0.000269	0.00264	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LPL—Alzheimer's disease	0.000246	0.00242	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTHFR—Alzheimer's disease	0.000221	0.00217	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CALM1—Alzheimer's disease	0.000207	0.00203	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOE—Alzheimer's disease	0.000206	0.00202	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CAV1—Alzheimer's disease	0.000204	0.00201	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARG—Alzheimer's disease	0.00018	0.00176	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INS—Alzheimer's disease	0.000176	0.00173	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NOS3—Alzheimer's disease	0.000154	0.00152	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS2—Alzheimer's disease	0.000141	0.00139	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKT1—Alzheimer's disease	7.1e-05	0.000697	CbGpPWpGaD
